Latest news

See more
23 jan, 2019 Grifols Announces Collaboration and License Agreement with Rigel Pharmaceuticals
Read more

05 nov, 2018 Bioscience Division revenues drive operational growth to 9.6% in the third quarter and boost net profits to Euros 468 million
Read more

27 oct, 2018 Grifols AMBAR results demonstrate a significant reduction in the progression of moderate Alzheimer's Disease
Read more

€4.3 billion


in 2017



€311 million

in R+D+i investments

in 2017

Executive report

Read more

Corporate responsibility report

Read more


Av. de la Generalitat 152-158
Parc empresarial Can Sant Joan
08174 Sant Cugat del Vallès,
Barcelona – España
+34 93 571 02 21




Subscribe to investors alerts

Subscribe to this service if you would like to receive by email the latest news for investors.